Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective

被引:14
|
作者
Dahdah, Nagib [1 ]
Fournier, Anne [1 ]
机构
[1] Univ Montreal, CHU Ste Justine, Div Pediat Cardiol, Montreal, PQ H3T 1C5, Canada
来源
DIAGNOSTICS | 2013年 / 3卷 / 01期
关键词
Kawasaki disease; myocarditis; NT-proBNP; hyponatremia; diagnosis; prognosis;
D O I
10.3390/diagnostics3010001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Making a diagnosis of Kawasaki disease with certainty may be challenging, especially since the recognition of cases with incomplete diagnostic criteria and its consequences. In order to build the diagnostic case in daily practice, clinicians rely on clinical criteria established over four decades ago, aided by non specific laboratory tests, and above all inspired by experience. We have recently studied the diagnostic value of N-terminal pro B-type natriuretic peptide to improve the diagnostic certainty of cases with complete or incomplete clinical criteria. Our working hypothesis was based on the fact that myocarditis is present in nearly all Kawasaki disease patients supported by histology data. In this paper, we review these facts and the myocardial perspective from the diagnostic and the mechanistic standpoints.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [31] Research perspective in the clinical management of Kawasaki disease
    Yi, Xiong-xiong
    Zhang, Wen-rong
    Wang, Dong-mei
    Wang, Xiu-ping
    Zhang, Fen-xia
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [32] Brain natriuretic peptide as a clinical screening tool for the diagnosis of Kawasaki disease
    Jung, Jae Ho
    Hwang, Soyun
    Jung, Jae Yun
    Park, Joong Wan
    Lee, Eui Jun
    Lee, Ha Ni
    Kim, Jin Hee
    Kim, Do Kyun
    Kwak, Young Ho
    MEDICINE, 2023, 102 (29) : E34319
  • [33] Natriuretic Peptide as an Adjunctive Diagnostic Test in the Acute Phase of Kawasaki Disease
    Dahdah, Nagib
    Siles, Ana
    Fournier, Anne
    Cousineau, Jocelyne
    Delvin, Edgard
    Saint-Cyr, Claire
    Spiegelblatt, Linda
    Bonny, Yvette
    Vartian, Michele
    Montigny, Martine
    PEDIATRIC CARDIOLOGY, 2009, 30 (06) : 810 - 817
  • [34] Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease
    Miyagawa, M
    Mochizuki, T
    Murase, K
    Tanada, S
    Ikezoe, J
    Sekiya, M
    Hamamoto, K
    Matsumoto, S
    Niino, M
    CIRCULATION, 1998, 98 (10) : 990 - 996
  • [35] Natriuretic peptides: Prediction of cardiovascular disease in the general population and high risk populations
    Hildebrandt, Per
    DISEASE MARKERS, 2009, 26 (5-6) : 227 - 233
  • [36] Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease
    Xie, Lijian
    Wang, Renjian
    Huang, Min
    Zhang, Yongwei
    Shen, Jie
    Xiao, Tingting
    CARDIOVASCULAR ULTRASOUND, 2016, 14
  • [37] Kawasaki Disease
    Sundel, Robert P.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (01) : 63 - +
  • [38] Clinical value of natriuretic peptides in chronic kidney disease
    Santos-Araujo, Carla
    Leite-Moreirab, Adelina
    Pestanac, Manuel
    NEFROLOGIA, 2015, 35 (03): : 227 - 233
  • [39] The natriuretic peptides as biomarkers for adults with congenital heart disease
    Nir, Amiram
    Luchner, Andreas
    Rein, Azaria J. J. T.
    BIOMARKERS IN MEDICINE, 2012, 6 (06) : 827 - 837
  • [40] Pathophysiology and significance of natriuretic peptides in patients with end disease
    Yang, Wen-ling
    Fahim, Magid
    Johnson, David W.
    CLINICAL BIOCHEMISTRY, 2020, 83 : 1 - 11